It has been shown that MAPK6 (ERK3) depletion markedly decreased oncogenic growth of mutant KRAS-mediated anchorage-independent growth of NSCLC cells [78], but no such data are available for PAAD. This evidence concerns the gene KRAS and non-small cell lung carcinoma.